Compare ALLR & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLR | ZGM |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | Macau |
| Employees | N/A | 9 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 17.7M |
| IPO Year | 2021 | N/A |
| Metric | ALLR | ZGM |
|---|---|---|
| Price | $1.07 | $1.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 177.3K | 5.5K |
| Earning Date | 05-08-2026 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.61 | $1.40 |
| 52 Week High | $2.35 | $4.44 |
| Indicator | ALLR | ZGM |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 38.80 |
| Support Level | $0.99 | N/A |
| Resistance Level | $1.14 | $2.26 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 25.79 | 26.58 |
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.